Basic Information
OcellO B.V. is a private contract research organization that provides CRO services to the drug discovery industry, significantly enhancing the efficiency of potential customer development. OcellO specializes in developing clinically relevant in vitro human micro-tissue models, which can be used for the screening and analysis of small molecules and biologics. OcellO's unique high-throughput 3D imaging and phenotypic analysis technology allows for the analysis of these models, many of which use patient-derived materials. In addition to providing measurements of cell growth and viability, phenotypic analysis can also measure more complex biology, leading to better correlation with clinical endpoints.